PMS5 Analyzing Costs Per Clinical Remission of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Rheumatoid Arthritis from a Public Perspective in Brazil

Autor: Buschinelli, C.T., Maximo, M.F.M., Tsuchiya, C.T., Tobaruella, F.S., Gonçalves, T.M.
Jazyk: angličtina
Zdroj: Value in Health. (7):A716
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.08.2217
Databáze: OpenAIRE